Assignee
HORIZON ORPHAN LLC
US·16 granted patents·13 pending applications·25 citations·filing 2015–2021
Top patents by PatentIndex Score
29 records- 0187US10987357B2Aerosolized fluoroquinolones and uses thereofHORIZON ORPHAN LLC·Filed 2019·Granted Apr 27, 2021·1 cites·13 claims
- 0287US10792289B2Use of aerosolized levofloxacin for treating cystic fibrosisHORIZON ORPHAN LLC·Filed 2019·Granted Oct 6, 2020·2 cites·8 claims
- 0386US10905662B2Methods for storing cysteamine formulations and related methods of treatmentHORIZON ORPHAN LLC·Filed 2019·Granted Feb 2, 2021·1 cites·18 claims
- 0486US10548859B2Methods for storing Cysteamine formulations and related methods of treatmentHORIZON ORPHAN LLC·Filed 2019·Granted Feb 4, 2020·1 cites·18 claims
- 0585US10328037B2Methods for storing cysteamine formulations and related methods of treatmentHORIZON ORPHAN LLC·Filed 2018·Granted Jun 25, 2019·1 cites·24 claims
- 0685US10231975B2Use of aerosolized levofloxacin for treating cystic fibrosisHORIZON ORPHAN LLC·Filed 2017·Granted Mar 19, 2019·4 cites·20 claims
- 0784US10149854B2Aerosol fluoroquinolone formulations for improved pharmacokineticsHORIZON ORPHAN LLC·Filed 2017·Granted Dec 11, 2018·2 cites·20 claims
- 0883US9951013B2Fucosidase inhibitorsHORIZON ORPHAN LLC·Filed 2016·Granted Apr 24, 2018·7 cites·24 claims
- 0982US10906904B2ADO-resistant cysteamine analogs and uses thereofHORIZON ORPHAN LLC·Filed 2016·Granted Feb 2, 2021·2 cites·4 claims
- 1082US10722519B2Aerosol fluoroquinolone formulations for improved pharmacokineticsHORIZON ORPHAN LLC·Filed 2018·Granted Jul 28, 2020·1 cites·10 claims
- 1174US10308607B2Fucosidase inhibitorsHORIZON ORPHAN LLC·Filed 2018·Granted Jun 4, 2019·2 cites·14 claims
- 1273US11090279B2Delayed release cysteamine bead formulation, and methods of making and using sameHORIZON ORPHAN LLC·Filed 2018·Granted Aug 17, 2021·0 cites·7 claims
- 1372US9879064B2Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereofHORIZON ORPHAN LLC·Filed 2015·Granted Jan 30, 2018·1 cites·12 claims
- 1472US2021121472A1Aerosol fluoroquinolone formulations for improved pharmacokineticsHORIZON ORPHAN LLC·Filed 2020·Application pending·0 cites
- 1570US2022080047A1Topical use of levofloxacin for reducing lung inflammationHORIZON ORPHAN LLC·Filed 2021·Application pending·0 cites
- 1667US11505550B2ADO-resistant cysteamine analogs and uses thereofHORIZON ORPHAN LLC·Filed 2021·Granted Nov 22, 2022·0 cites·2 claims
- 1767US11020481B2Topical use of levofloxacin for reducing lung inflammationHORIZON ORPHAN LLC·Filed 2017·Granted Jun 1, 2021·0 cites·5 claims
- 1867US10143665B2Methods for storing cysteamine formulations and related methods of treatmentHORIZON ORPHAN LLC·Filed 2016·Granted Dec 4, 2018·0 cites·8 claims
- 1967US2021228589A1Use of aerosolized levofloxacin for treating cystic fibrosisHORIZON ORPHAN LLC·Filed 2020·Application pending·0 cites
- 2060US2017319512A1Delayed release cysteamine bead formulation, and methods of making and using sameHORIZON ORPHAN LLC·Filed 2017·Application pending·0 cites
- 2160US2017319514A1Delayed release cysteamine bead formulation, and methods of making and using sameHORIZON ORPHAN LLC·Filed 2017·Application pending·0 cites
- 2260US2017319513A1Delayed release cysteamine bead formulation, and methods of making and using sameHORIZON ORPHAN LLC·Filed 2017·Application pending·0 cites
- 2356US2022047604A1Aerosolized fluoroquinolones and uses thereofHORIZON ORPHAN LLC·Filed 2021·Application pending·0 cites
- 2454US2018098964A1Genotype specific methods for treating human subjects using 4-methylpyrazoleHORIZON ORPHAN LLC·Filed 2017·Application pending·0 cites
- 2554US2018118802A1Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereofHORIZON ORPHAN LLC·Filed 2017·Application pending·0 cites
- 2653US2021015811A1Methods of treating a pulmonary bacterial infection using fluoroquinolonesHORIZON ORPHAN LLC·Filed 2020·Application pending·0 cites
- 2747US2021113496A1Methods of Treating Excitotoxicity DisordersHORIZON ORPHAN LLC·Filed 2019·Application pending·0 cites
- 2845US2018292366A1Methods for analyzing cysteamine compositionsHORIZON ORPHAN LLC·Filed 2018·Application pending·0 cites
- 2945US2021113579A1Fluoroquinolone formulations for cystic fibrosisHORIZON ORPHAN LLC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HORIZON ORPHAN LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →